These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8629885)

  • 1. Isoniazid preventive therapy in areas of high isoniazid resistance.
    Moulding T
    Arch Intern Med; 1996 Mar; 156(6):685-6. PubMed ID: 8629885
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance in tuberculosis.
    Prasad TR
    J Indian Med Assoc; 1975 May; 64(10):264-7. PubMed ID: 1176782
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid preventive therapy.
    Salpeter SR
    Arch Intern Med; 1996 Apr; 156(7):811. PubMed ID: 8615716
    [No Abstract]   [Full Text] [Related]  

  • 4. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of isoniazid preventive therapy.
    Rose DN
    Arch Intern Med; 1996 Mar; 156(6):684-5. PubMed ID: 8629883
    [No Abstract]   [Full Text] [Related]  

  • 6. It is too early to discount the contribution of isoniazid to the treatment of tuberculous meningitis.
    Seaworth BJ
    J Infect Dis; 2005 Jul; 192(1):10-2. PubMed ID: 15942887
    [No Abstract]   [Full Text] [Related]  

  • 7. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
    Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Moulding T
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings].
    Yoshiyama T
    Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis in Turkish children.
    Dilber E; Göçmen A; Kiper N; Ozçelik U
    Turk J Pediatr; 2000; 42(2):145-7. PubMed ID: 10936981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis.
    Thwaites GE; Chau TT; Caws M; Phu NH; Chuong LV; Sinh DX; Drobniewski F; White NJ; Parry CM; Farrar JJ
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):865-71. PubMed ID: 12365572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
    Warndorff DK; Yates M; Ngwira B; Chagaluka S; Jenkins PA; Drobniewski F; Pönnighaus JM; Glynn JR; Fine PE
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):752-7. PubMed ID: 10949327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.